期刊文献+

α_1-酸性糖蛋白柱拆分西酞普兰对映异构体 被引量:7

Enantiomeric separation of citalopram by HPLC using α_1-acid glycoprotein chiral stationary phase
下载PDF
导出
摘要 目的:建立西酞普兰对映异构体的拆分方法。方法:采用α1-酸性糖蛋白(AGP)手性柱固定相,考察了流动相组成、pH值、流速、柱温、有机改性剂对拆分的影响,优化后色谱条件为Chrom Tech CHIRAL-AGP柱(150 mm×4.0 mm,5μm),流动相为50 mmol/L醋酸铵缓冲液(乙酸调节pH至4.3),流速0.8 mL/min,检测波长240 nm,柱温25℃。结果:西酞普兰对映异构体保留时间分别为6.8和8.4 min,能够达到基线分离。结论:缓冲盐浓度和pH值是影响对映体分离的重要因素,同时可以在一定范围内调节流速和柱温来提高柱效,改善分离。 Aim: To develop a chiral separation method for enantiomers of citalopram by HPLC using α1-acid glycoprotein (α1-AGP) chiral stationary phase. Methods:Influences of the pH value of the mobile phase, the kind and concentration of the buffer solution, organic modifiers, the flow rate and the column temperature on the enantiomeric separation of citalopram using α1-AGP chiral stationary phase were investigated. Results: Citalopram enantiomers were separated on an α1-AGP chiral stationary phase column using water as the mobile phase consisting of 50 mmol/L NH4Ac buffer (pH = 4.3) at a flow rate of 0.8 mL/min. Conclusion: The pH value of the mobile phase and the concentration of the buffer solution are very important parameters in the optimization of the enantiomeric separation of the cationic racemates. Higher column efficiency can be achieved with lower flow rate.
作者 杨倩 刘文英
出处 《中国药科大学学报》 CAS CSCD 北大核心 2007年第3期243-246,共4页 Journal of China Pharmaceutical University
关键词 西酞普兰 对映体 手性拆分 Α1-酸性糖蛋白 citalopram enantiomers enantiomeric separation α1-acid glycoprotein
  • 相关文献

参考文献8

二级参考文献34

  • 1Masilamani S,Ruppelt SC.Escitalopram (Lexapro) for depression[J].Am Fam Physician,2003,68(1 1):2235-6.
  • 2Croom KF,Plosker GL.Escitalopram:a pharmacoeconomic review of its use in depression[J].Pharmacoeconomics,2003,21 (16):1185-209.
  • 3Lepola UM,Loft H,Reines EH.Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care[J].Int Clin Psychopharmacol,2003,18(4):211-7.
  • 4Svensson S,Mansfield PR.Escitalopram:superior to citalopram or a chiral chimera[J]? Psychother Psychosom,2004,73(1):10-6.
  • 5Hyttel J,Bogeso KP,PerregaardJ,et al.The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer [J].JNeural Trans (Gen Sect),1992,88(2):157-60.
  • 6Kosel M,Eap CB,Amey M,et al.Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography[J].JChromatogr B Biomed Sci Appl,1998,719(1-2):234-8.
  • 7Sorbera LA, Revel L, Martin L, et al. Escitalopram oxalate [J]. Drugs Future, 2001, 26(2): 115-120.
  • 8Kang JW, Wistuba D, Schurig V. Fast enantiomeric separation with vancomycin as chiral additive by co-electroosmotic flow capillary electrophoresis:Increase of the detection sensitivity by the partial filling technique [J]. Electrophoresis, 2003,24 (15): 2
  • 9Dan Haupt. Determination of citalopram enantiomers in human plasma by liquid chromatographic separation on aChiral-AGP column [J]. J ChromatogrB, 1996, 685 (2): 299-305.
  • 10Carlsson B, Norlander B. Optimization and characterization of the chiral separation of citalopram and its demethylated metabolites by response-surface methodology [J] .Chromatographia, 2001, 53 (5/6): 266-272.

共引文献42

同被引文献57

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部